Screening for insulitis in adult autoantibody-positive organ donors

Diabetes

Volumn 56, Issue 9, 2007, Pages 2400-2404

  In't Veld, Peter ^a   Lievens, Dirk ^a   De Grijse, Joeri ^a   Ling, Zhidong ^a   Van Der Auwera, Bart ^a   Pipeleers Marichal, Miriam ^a   Gorus, Frans ^a   Pipeleers, Daniel ^a  

^a FREE UNIVERSITY OF BRUSSELS   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CD3 ANTIGEN; CD8 ANTIGEN; GLUTAMATE DECARBOXYLASE; INSULIN ANTIBODY; KI 67 ANTIGEN; PANCREAS ISLET CELL ANTIBODY;

ADULT; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; GENOTYPE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INSULIN DEPENDENT DIABETES MELLITUS; INSULINOMA; INSULITIS; MAJOR CLINICAL STUDY; MALE; ORGAN DONOR; PANCREAS ISLET CELL; PRIORITY JOURNAL; RISK FACTOR;

ADULT; AUTOANTIBODIES; BIOLOGICAL MARKERS; DIABETES MELLITUS, TYPE 1; GENETIC MARKERS; HUMANS; INSULIN; INSULIN ANTIBODIES; INSULIN-SECRETING CELLS; MASS SCREENING; PANCREATIC DISEASES; PATIENT SELECTION; TISSUE BANKS; TISSUE DONORS;

EID: 34548397755     PISSN: 00121797     EISSN: 00121797     Source Type: Journal    
DOI: 10.2337/db07-0416     Document Type: Article

References (26)

1. Gepts W: Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes 14:619-633, 1965
2. Bottazzo GF, Dean BM, McNally JM, MacKay EH, Swift PGF, Gamble DR: In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis. N Engl J Med 313:353-360, 1985
3. Foulis AK, Liddle CN, Farquharson MA, Richmond JA, Weir RS: The histopathology of the pancreas in type 1 (insulin-dependent) diabetes mellitus: a 25-year review of deaths in patients under 20 years of age in the United Kingdom. Diabetologia 29:267-274, 1986
4. Pipeleers D, Ling Z: Pancreatic cells in insulin-dependent diabetes. Diabetes Metab Rev 8:209-227, 1992
5. Roep BO: The role of T-cells in the pathogenesis of type 1 diabetes: from cause to cure. Diabetologia 46:305-321, 2003
6. Bingley PJ, Bonifacio E, Gale EAM: Can we really predict IDDM? Diabetes 42:213-220, 1993
7. Gorus FK, Pipeleers DG, the Belgian Diabetes Registry: Prospects for predicting and stopping the development of type 1 of diabetes. Best Pract Res Clin Endocrinol Metab 15:371-389, 2001
8. Verge CF, Gianani R, Kawasaki E, Yu L, Pietropaola M, Jackson RA, Chase HP, Eisenbarth GS: Prediction of type 1 diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies. Diabetes 45:926-933, 1996
9. Kulmala P, Savola K, Petersen JS, Vahasalo P, Karjalainen J, Lopponen T, Dyrberg T, Akerblom HK, Knip M, the Childhood Diabetes in Finland Study Group: Prediction of insulin-dependent diabetes mellitus in siblings of children with diabetes: a population-based study. J Clin Invest 101:327-336, 1998
10. Leslie RDG, Atkinson MA, Notkins AL: Autoantigens IA-2 and GAD in type I (insulin-dependent) diabetes. Diabetologia 42:3-14, 1999
11. Bingley PJ, Christie MR, Bonifacio E, Bonfanti R, Shattock M, Fonte MT, Botazzo GF, Gale EAM: Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives. Diabetes 43:1304-1310, 1994
12. Maclaren N, Lan M, Coutant R, Schatz D, Silverstein J, Muir A, Clare-Selzer M, She JX, Malone J, Crockett S, Schwartz S, Quattrin T, DeSilva M, Vander Vegt P, Notkins A, Krischer J: Only multiple autoantibodies to islet cells (IAC), insulin, GAD65, and IA-2beta predict immune-mediated (type 1) diabetes in relatives. J Autoimmunity 12:279-287, 1999
13. Wagner R, McNally JM, Bonifacio E, Genovese S, Foulis A, McGill M, Christie MR, Betterle C, Bosi E, Botazzo GF: Lack of immunohistologic changes in the islets of nondiabetic, autoimmune, polyendocrine patients with β-selective GAD-specific islet cell antibodies. Diabetes 43:851-856, 1994
14. Gianani R, Putnam A, Still T, Yu L, Miao D, Gill RG, Beilke J, Supon P, Valentine A, Iveson A, Dunn S, Eisenbarth GS, Hutton J, Gottlieb P, Wiseman A: Initial results of screening of non-diabetic organ donors for expression of islet autoantigens. J Clin Endocrin Metab 91:1855-1861, 2006
15. Keymeulen B, Ling Z, Gorus F, Delvaux G, Bouwens L, Grupping A, Hendrieckx C, Pipeleers-Marichal M, Van Schravendijk C, Salmema K, Pipeleers DG: Implantation of standardized β-cell grafts in liver segment of IDDM patients: graft and recipient characteristics in two cases of insulinindependence under maintenance immunosuppression for prior kidney graft. Diabetologia 41:452-459, 1998
16. Keymeulen B, Gillard P, Mathieu C, Movahedi B, Maleux G, Delvaux G, Ysebaert D, Rope B, Vandemeulebroucke E, Marichal M, In't Veld P, Bogdani M, Hendrieckx C, Gorus F, Ling Z, van Rood J, Pipeleers D: Correlation between beta cell mass and glycemic control in type 1 diabetic recipients of islet cell graft. Proc Natl Acad Sci U S A 103:17444-17449, 2006
17. Decochez K, Truyen I, Van der Auwera B, Weets I, Vandermeulebroucke E, De Leeuw IH, Keymeulen B, Mathieu C, Rottiers R, Pipeleers DG, Gorus FK: Combined positivity for HLA DQ2/DQ8 and IA-2 autoantibodies defines population at high risk of developing type 1 diabetes. Diabetologia 48:687-694, 2005
18. Van der Auwera BJ, Schuit FC, Weets I, Ivens A, Van Autreve J, Gorus FK, the Belgian Diabetes Registry: Relative and absolute HLA-DQA1-DQB1-linked risk for developing type 1 diabetes before 40 years of age in the Belgian population: implications for future prevention studies. Hum Immunol 63:40-50, 2002
19. Rahier J, Wallon J, Henquin JC: Cell populations in the endocrine pancreas of human neonates and infants. Diabetologia 20:540-546, 1981
20. Hosszufalusi N, Vatay A, Rajcczy K, Prohaszka Z, Pozsonyi E, Horvath L, Grosz A, Gero L, Madacsy L, Romics L, Karadi I, Fust G, Panczel P: Similar genetic features and different islet cell autoantibody patterns of latent autoimmune diabetes in adults (LADA) compared with adult-onset type 1 diabetes with rapid progression. Diabetes Care 26:452-547, 2003
21. Zimmet PZ, Tuomi T, Mackay IR, Rowley MJ, Knowles W, Cohen M, Lang DA: Latent autoimmune diabetes in adults (LADA): the role of antibodies to glutamic acid decarboxylase in diagnosis and prediction of insulin dependency. Diabet Med 11:299-303, 1994
22. Kobayashi T, Tamemoto K, Nakanishi K, Kato N, Okubo M, Kajio H, Sugimoto T, Murase T, Kosaka K: Immunogenetic and clinical characterization of slowly progressive IDDM. Diabetes Care 16:780-788, 1993
23. + diabetes with residual β-cell function. Diabetes Care 22:615-617, 1999
24. Hänninen A, Jalkanen S, Samli M, Toikkanen S, Nikolarakos G, Simell O: Macrophages, T cell receptor usage, and endothelial cell activation in the pancreas at the onset of insulin-dependent diabetes mellitus. J Clin Invest 90:1901-1910, 1992
25. Somoza N, Vargas F, Roura-Mir C, Vives-Pi M, Fernandez-Figueras MT, Ariza A, Gomis R, Bragado R, Marti M, Jaraquemada D, Pujol-Borrell R: Pancreas in recent-onset insulin-dependent diabetes mellitus: changes in HLA, adhesion molecules and autoantigens, restricted T cell receptor Vbeta usage, and cytokine profile. J Immunol 153:1360-1377, 1994
26. Sibley RK, Sutherland DER, Goetz F, Michael AF: Recurrent diabetes mellitus in the pancreas iso- and allograft: a light and electron microscopic and immuno-histochemical analysis of four cases. Lab Invest 53:132-144, 1985